Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy

Brain

Volumn 123, Issue 8, 2000, Pages 1660-1666

  Murata, Ken ya ^a   Dalakas, Marinos C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antigen presenting cells; Chronic inflammatory demyelinating polyneuropathy; Co stimulatory molecules; Immunohistological study; RT PCR

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN S 100;

ANTIGEN PRESENTING CELL; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NERVE BIOPSY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; SURAL NERVE;

EID: 0033939270     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.8.1660     Document Type: Article

References (31)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). [Review]. Neurology 1991; 41: 617-8.
2. 2-specific CD4+ T-cell lines. J Neuroimmunol 1992; 40: 1-18.
3. Behrens L, Kerschensteiner M, Misgeld T, Goebels N, Wekerle H, Hohlfeld R. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 1998; 161: 5943-51.
4. Bigbee JW, Yoshino JE, DeVries GH. Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J Neurocytol 1987; 16: 487-96.
5. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993; 90: 11059-63.
6. Cadoni A, Zicca A, Mancardi GL. Schwann cell expression of HLA-DR antigen in peripheral neuropathies [letter]. Lancet 1986; 2: 1282-3.
7. Dalakas MC. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. Curr Opin Neurol 1999; 12: 403-9.
8. Dariavach P, Mattéi MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988; 18: 1901-5.
9. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 1995; 54: 175-87.
10. Dyck PJ, Prineas J, Pollard J. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders; 1993. p. 1498-517.
11. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988; 263: 15335-41.
12. Ford AL, Britton WJ, Armati PJ. Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes. J Neuroimmunol 1993; 43: 151-9.
13. Freeman GJ, Cardoso AA, Boussiotis VA, Anumanthan A, Groves RW, Kupper TS, et al. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J Immunol 1998; 161: 2708-15.
14. Gold R, Toyka KV, Hartung HP. Synergistic effect of IFN-γ and TNF-α on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 1995; 165: 65-70.
15. Gold R, Archelos JJ, Hartung HP. Mechanisms of immune regulation in the peripheral nervous system. [Review]. Brain Pathol 1999; 9: 343-60.
16. Hartung HP, Reiners K, Toyka KV, Pollard JD. Guillain-Barré syndrome and CIDP. In: Hohlfeld R, editor. Immunology of neuromuscular disease. Dordrecht: Kluwer Academic; 1994. p. 33-104.
17. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1992; 107: 111-21.
18. Jessen KR, Mirsky R. Nonmyelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3 antigen and glial fibrillary acidic protein. J Neurocytol 1984; 13: 923-34.
19. Jessen KR, Mirsky R. Glial fibrillary acidic polypeptides in peripheral glia. Molecular weight, heterogeneity and distribution. J Neuroimmunol 1985; 8: 377-93.
20. Lee KP, Taylor C, Petryniak B, Turka LA, June CH, Thompson CB. The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J Immunol 1990; 145: 344-52.
21. Mancardi GL, Cadoni A, Zicca A, Schenone A, Tabaton M, De Martini I, et al. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 1988; 38: 848-51.
22. Mathey EK, Pollard JD, Armati PJ. TNFα, IFNγ and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 1999; 163: 47-52.
23. Murata K, Dalakas MC. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 1999; 155: 453-60.
24. Nickoloff BJ, Mitra RS, Lee K, Turka LA, Green J, Thompson C, et al. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol 1993; 142: 1029-40.
25. Pollard JD. Chronic inflammatory demyelinating polyradiculo-neuropathy. [Review]. Baillière's Clin Neurol 1994; 3: 107-27.
26. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. [Review]. N Engl J Med 1996; 335: 1369-77.
27. Scarpini E, Meola G, Baron P, Beretta S, Velicogna M, Scarlato G. S-100 protein and laminin: immunocytochemical markers for human Schwann cells in vitro. Exp Neurol 1986; 93: 77-83.
28. Scarpini E, Lisak RP, Beretta S, Velicogna M, Doronzo R, Moggio M, et al. Quantitative assessment of class II molecules in normal and pathological nerves. Immunocytochemical studies in vivo and in tissue culture. Brain 1990; 113: 659-75.
29. Seko Y, Takahashi N, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, et al. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 1998; 97: 637-9.
30. Trapp BD. Myelin-associated glycoprotein. Location and potential functions. [Review]. Ann NY Acad Sci 1990; 605: 29-43.
31. Wekerle H, Schwab M, Linington C, Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 1986; 16: 1551-7.